Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

During pancreatic development, proliferating pancreatic progenitors activate the proendocrine transcription factor neurogenin 3 (NEUROG3), exit the cell cycle, and differentiate into islet cells. The mechanisms that direct robust NEUROG3 expression within a subset of progenitor cells control the size of the endocrine population. Here we demonstrate that NEUROG3 is phosphorylated within the nucleus on serine 183, which catalyzes its hyperphosphorylation and proteosomal degradation. During progression through the progenitor cell cycle, NEUROG3 phosphorylation is driven by the actions of cyclin-dependent kinases 2 and 4/6 at G1/S cell-cycle checkpoint. Using models of mouse and human pancreas development, we show that lengthening of the G1 phase of the pancreatic progenitor cell cycle is essential for proper induction of NEUROG3 and initiation of endocrine cell differentiation. In sum, these studies demonstrate that progenitor cell-cycle G1 lengthening, through its actions on stabilization of NEUROG3, is an essential variable in normal endocrine cell genesis.

Original publication

DOI

10.1016/j.devcel.2017.02.006

Type

Journal article

Journal

Dev Cell

Publication Date

24/04/2017

Volume

41

Pages

129 - 142.e6

Keywords

CRISPR/Cas9, Cdkn1b, G1 lengthening, Kras, Ngn3, Sox9-rTTA, diabetes, human embryonic stem cells, insulin, mouse, Animals, Basic Helix-Loop-Helix Transcription Factors, Cell Cycle, Cell Differentiation, Endocrine Cells, Gene Expression Regulation, Developmental, Humans, Islets of Langerhans, Mice, Nerve Tissue Proteins, Pancreas, Phosphorylation, Stem Cells